PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LH vs. DGX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LH and DGX is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

LH vs. DGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX). The values are adjusted to include any dividend payments, if applicable.

3,000.00%3,500.00%4,000.00%4,500.00%5,000.00%5,500.00%6,000.00%6,500.00%AugustSeptemberOctoberNovemberDecember2025
3,747.37%
5,886.22%
LH
DGX

Key characteristics

Sharpe Ratio

LH:

0.40

DGX:

0.77

Sortino Ratio

LH:

0.75

DGX:

1.35

Omega Ratio

LH:

1.09

DGX:

1.15

Calmar Ratio

LH:

0.33

DGX:

0.62

Martin Ratio

LH:

1.25

DGX:

4.06

Ulcer Index

LH:

7.04%

DGX:

3.80%

Daily Std Dev

LH:

21.74%

DGX:

19.98%

Max Drawdown

LH:

-96.05%

DGX:

-49.46%

Current Drawdown

LH:

-8.17%

DGX:

-7.29%

Fundamentals

Market Cap

LH:

$19.97B

DGX:

$16.93B

EPS

LH:

$5.27

DGX:

$7.42

PE Ratio

LH:

45.27

DGX:

20.38

PEG Ratio

LH:

0.51

DGX:

1.77

Total Revenue (TTM)

LH:

$9.68B

DGX:

$7.25B

Gross Profit (TTM)

LH:

$2.61B

DGX:

$2.34B

EBITDA (TTM)

LH:

$1.36B

DGX:

$1.39B

Returns By Period

In the year-to-date period, LH achieves a 4.03% return, which is significantly higher than DGX's 0.72% return. Over the past 10 years, LH has underperformed DGX with an annualized return of 9.45%, while DGX has yielded a comparatively higher 10.38% annualized return.


LH

YTD

4.03%

1M

5.41%

6M

13.56%

1Y

6.72%

5Y*

10.29%

10Y*

9.45%

DGX

YTD

0.72%

1M

0.28%

6M

4.58%

1Y

16.46%

5Y*

9.48%

10Y*

10.38%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LH vs. DGX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LH
The Risk-Adjusted Performance Rank of LH is 5757
Overall Rank
The Sharpe Ratio Rank of LH is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of LH is 5353
Sortino Ratio Rank
The Omega Ratio Rank of LH is 5151
Omega Ratio Rank
The Calmar Ratio Rank of LH is 6161
Calmar Ratio Rank
The Martin Ratio Rank of LH is 6060
Martin Ratio Rank

DGX
The Risk-Adjusted Performance Rank of DGX is 7070
Overall Rank
The Sharpe Ratio Rank of DGX is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 6868
Sortino Ratio Rank
The Omega Ratio Rank of DGX is 6363
Omega Ratio Rank
The Calmar Ratio Rank of DGX is 7070
Calmar Ratio Rank
The Martin Ratio Rank of DGX is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LH vs. DGX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LH, currently valued at 0.40, compared to the broader market-2.000.002.004.000.400.77
The chart of Sortino ratio for LH, currently valued at 0.75, compared to the broader market-4.00-2.000.002.004.000.751.35
The chart of Omega ratio for LH, currently valued at 1.09, compared to the broader market0.501.001.502.001.091.15
The chart of Calmar ratio for LH, currently valued at 0.33, compared to the broader market0.002.004.006.000.330.62
The chart of Martin ratio for LH, currently valued at 1.25, compared to the broader market-10.000.0010.0020.0030.001.254.06
LH
DGX

The current LH Sharpe Ratio is 0.40, which is lower than the DGX Sharpe Ratio of 0.77. The chart below compares the historical Sharpe Ratios of LH and DGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.40
0.77
LH
DGX

Dividends

LH vs. DGX - Dividend Comparison

LH's dividend yield for the trailing twelve months is around 1.51%, less than DGX's 1.98% yield.


TTM20242023202220212020201920182017201620152014
LH
Laboratory Corporation of America Holdings
1.51%1.57%1.18%0.92%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DGX
Quest Diagnostics Incorporated
1.98%1.96%2.02%2.08%1.40%1.85%1.99%2.34%1.83%1.72%2.07%1.92%

Drawdowns

LH vs. DGX - Drawdown Comparison

The maximum LH drawdown since its inception was -96.05%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for LH and DGX. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.17%
-7.29%
LH
DGX

Volatility

LH vs. DGX - Volatility Comparison

The current volatility for Laboratory Corporation of America Holdings (LH) is 4.01%, while Quest Diagnostics Incorporated (DGX) has a volatility of 4.93%. This indicates that LH experiences smaller price fluctuations and is considered to be less risky than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
4.01%
4.93%
LH
DGX

Financials

LH vs. DGX - Financials Comparison

This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab